PatientsVille.com Logo

PAIN IN EXTREMITY and Potassium

PatientsVille

PAIN IN EXTREMITY Symptoms and Causes

Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a pulmonary embolism.

Sitting still for a long time can make you more likely to get a DVT. Some medicines and disorders that increase your risk for blood clots can also lead to DVTs. Common symptoms are

  • Warmth and tenderness over the vein
  • Pain or swelling in the part of the body affected
  • Skin redness

Treatment includes medicines to ease pain and inflammation, break up clots and keep new clots from forming. Keeping the affected area raised and applying moist heat can also help. If you are taking a long car or plane trip, take a break, walk or stretch your legs and drink plenty of liquids.

Check out the latest treatments for PAIN IN EXTREMITY

PAIN IN EXTREMITY treatment research studies

Potassium clinical trials, surveys and public health registries


Find Drug Side Effect reports



Potassium Side Effects

Hyperkalaemia (64)
Nausea (46)
Pain (45)
Dyspnoea (43)
Dizziness (42)
Asthenia (41)
Fatigue (37)
Cardiac Arrest (34)
Diarrhoea (33)
Completed Suicide (29)
Vomiting (28)
Renal Failure (28)
Oedema Peripheral (27)
Chest Pain (26)
Anxiety (26)
Pain In Extremity (25)
Muscle Spasms (25)
Fall (24)
Death (24)
Pyrexia (23)
Headache (22)
Weight Decreased (22)
Hypersensitivity (21)
Blood Potassium Increased (21)
Renal Failure Acute (20)
Arthralgia (20)
Injury (19)
Abdominal Pain (19)
Cough (19)
Hypotension (19)
Pneumonia (18)
Dehydration (18)
Abdominal Pain Upper (18)
Back Pain (18)
Confusional State (17)
Anaemia (17)
Depression (17)
Hypertension (17)
Overdose (17)
Malaise (17)
Cerebrovascular Accident (16)
Hypokalaemia (16)
Rash (15)
Respiratory Failure (15)
Injection Site Pain (15)
Cardiac Failure Congestive (15)
Blood Potassium Decreased (14)
Feeling Abnormal (14)
Product Quality Issue (14)
Thrombocytopenia (14)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

BLOOD rEPORT TOO HIGH 6.8

High potassium what are the side effects

I have takesn ecoclav dua for thorate infection what is harm

I want to know whether losartan casuse erectile disfunction ( E D )

I took Beano (only one pill) last week and 2 hours later I ended up with a terrible stomach pain.I did not connect the dots, I suspected that it was caused by certain ingredients in the food I was eating. Itwas a very unique pain

Yesterday, after taking Sam-e with Glucosamine. I got a pain between my shoulder blade, jaw pain, dizziness, sweating. felt like a heart attack. I did not go to the hospital because of the money needed. No ins

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

63 yo man received Zostavax injection in the left upper arm 12/13/11. Developed painful blister on the right shoulder and pain at the right lower ribs 12/10/11.

After using Clobetasol for a two week cycle, my doctor suggested I use it one day during the week, applying it twice that day. Since that time, I have experinced severe chest pain. I recently saw my doctor for heart attack symptoms before I reali

Arthritis Treatment Safe, Natural Cure for Adults. Synflex Liquid Glucosamine, Rheumatoid Arthritis Joint Pain Relief Remedy, Diet Supplements. Synflex, Glucosamine for Dogs. Free Shipping! &lt;a href='http://www.healthyjointcare.com/'&g

My father is 68 and retired, he is also diabetic. He suffers from severe joints, hip and back pain. He has been using panadol extra strength but finds it takes too long to act. He is also allergic to aspirin and was hospitalized with a ruptured u

While taking Pradaxa I had severe knife feeling pain in left eye. I have been off 2 days and it is better. I will check with eye docotr this week and see if it is eye or meds.

Yes I am Aspavor 20mg and also have a back pain were I am constantly taking pain killers. I actually thought that I did some thing wrong by lifting but just from sitting or turning my body it will return it starts to effect my job off shore and h

i feel nick pain & headache i am ussed 9th month

PAIN IN EXTREMITY Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Bioavailability of Potassium From Potatoes and Potassium Gluconate
Conditions: Potassium Bioavailability;   Blood Pressure
Interventions: Dietary Supplement: Placebo control;   Dietary Supplement: Low dose Potassium gluconate;   Dietary Supplement: Medium dose Potassium gluconate;   Dietary Supplement: High dose Potassium gluconate;   Dietary Supplement: Low dose potato;   Dietary Supplement: Medium dose potato;   Dietary Supplement: High dose potato;   Dietary Supplement: High dose French fries;   Dietary Supplement: Basal diet control
Outcome Measures: Bioavailability of Potassium;   Blood Pressure Response to Potassium
2 Not yet recruiting Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions
Condition: Hyperkalemia
Intervention: Behavioral: decision support in Potassium-inc. drug-drug-interactions
Outcome Measures: Impact on serum Potassium monitoring during Potassium-increasing drug-drug-interactions;   Frequency of hyperkalemia during Potassium-increasing drug-drug-interactions;   Frequency of Potassium-increasing drug-drug-interactions ordered in the presence of hyperkalemia;   Frequency of transfers to the ICU during Potassium-increasing drug-drug-interactions in function of the serum Potassium level;   Frequency of death during Potassium-increasing drug-drug-interactions in the presence or absence of hyperkalemia;   Change in frequency distribution of serum Potassium monitoring intervals;   Response of physicians to the computer-based alerts and reminders
3 Recruiting Comparison of Enteral Versus Intravenous Potassium Supplementation
Condition: Acute Hypokalemia
Interventions: Drug: Intravenous Potassium chloride;   Drug: Oral Potassium chloride
Outcome Measures: The efficacy EPR and IVPR for treatment of hypokalemia (measured as change in serum Potassium levels in milliequivalent/liter (mEq/L) after Potassium replacement;   Comparison of adverse effects after EPR and IVPR.;   Comparison of number of dose/s required to achieve resolution of hypokalemia;   Efficacy of EPR and IVPR for various degrees of severity of hypokalemia for each episode of hypokalemia
4 Unknown  Effect of Rapid Transfusion With Fluid Management System (FMS) on Plasma Potassium in Liver Transplantation Recipients
Condition: Condition Requiring Rapid Transfusion During Liver Transplantation Surgery
Intervention:
Outcome Measures: Potassium concentration in the Fluid Management System (FMS) reservoir;   plasma Potassium of the patient
5 Not yet recruiting Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature
Condition: Nephrocalcinosis
Interventions: Drug: Potassium Citrate;   Drug: Placebo
Outcome Measures: incidence of nephrocalcinosis in extremely preterm infants;   Determine whether the administration of Potassium citrate in extreme premature decreases neonates the levels of calcium and calcium / creatinine ratio in urine in each of the branches of treatment at 38-40 weeks;   To determine whether administration of Potassium citrate improves the levels of urinary phosphorus, Potassium, sodium, citrate, creatinine, oxalate, ratio citrate / calcium , and ph value;   Determine whether the administration of Potassium citrate improves the plasma levels of sodium, Potassium, creatinine, calcium, and ph value.;   To determine the incidence of adverse events and serious adverse events related to study treatment.
6 Unknown  Effects of Potassium Salts on Blood Pressure and Target Organ Damage
Condition: Hypertension
Intervention: Behavioral: Potassium supplementation
Outcome Measures: Blood pressure and markers of target organ damage and bone health at 4 weeks of Potassium supplementation.;   Comparisons among different treatments in blood pressure and markers of target organ damage and bone health.
7 Recruiting Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension
Condition: Hypertension
Interventions: Drug: Potassium chloride powder;   Drug: Potassium citrate powder;   Drug: Potassium magnesium citrate powder;   Drug: Placebo
Outcome Measures: 24-hour blood pressure;   Office blood pressure;   Serum C-terminal telopeptide (CTX);   24-hour urinary calcium;   Carotid to femoral pulse wave velocity;   Central aortic blood pressure
8 Recruiting Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
Conditions: Atrial Fibrillation;   Atrial Flutter;   Potassium;   Cardioversion
Intervention: Drug: Potassium chloride
Outcome Measures: Cardioversion (time and percentage);   Atrial fibrillation at 3 months follow up visit and during 72 hours ECG-monitoring period.
9 Recruiting Combined Dietary Education of Low Sodium and High Potassium Consumption
Conditions: Prehypertension;   Hypertension
Interventions: Behavioral: dietary education of low sodium and high Potassium consumption;   Behavioral: dietary education of low sodium consumption only
Outcome Measures: changes of 24-hour ambulatory systolic and diastolic blood pressure;   changes of 24-hour urine sodium and Potassium excretion;   changes of renin and aldosterone
10 Not yet recruiting Investigating a New Way of Giving Medicine to Newborn and Preterm Babies
Conditions: Hypophosphataemia;   Osteopenia of Prematurity
Interventions: Drug: Oral thin film therapy (Potassium acid phosphate oral thin films);   Drug: Standard therapy (Potassium acid phosphate oral solution)
Outcome Measures: Serum phosphate;   Age-appropriateness
11 Unknown  Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Condition: Acute Coronary Syndrome
Interventions: Drug: glucose insulin Potassium;   Drug: GIK and intensive insulin therapy
Outcome Measures: 30 days mortality, reinfarction, urgent coronary revascularisation, and stroke.;   Severe dysrhythmias, acute left ventricular failure with ejection fraction<45%, change of serum B-type natriuretic peptide (BNP), serum troponin, and platelet factor activator (PFA-100) within 24 hours after the start of protocol treatment.
12 Recruiting Potassium Citrate Supplementation vs. Dietary Counseling
Condition: Kidney Stone
Interventions: Dietary Supplement: Potassium Citrate Supplementation;   Other: Dietary Education
Outcome Measure: Change in 24-hour urine parameters
13 Recruiting Musculoskeletal Effects of Bicarbonate
Conditions: Age-related Bone Loss;   Age Related Muscle Loss;   Falls;   Fractures
Interventions: Dietary Supplement: Potassium bicarbonate;   Other: placebo
Outcome Measures: The primary aim is to identify the dose of KHCO3 needed for maximal suppression of 24-hr urinary N-telopeptide/creatinine ratio;   The secondary aim is to identify the dose of KHCO3 needed for maximal suppression of 24-hr urinary nitrogen/creatinine ratio
14 Recruiting Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Tegafur, Gimeracil and Oteracil Potassium Capsules;Oxaliplatin;   Drug: Oxaliplatin; Capecitabine
Outcome Measures: Disease-free survival(DFS);   Objective response rate (ORR);   Disease control rate (DCR);   Down staging rate;   Overall survival (OS);   Adverse events;   R0-resection rate
15 Unknown  Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium;   Drug: Placebo
Outcome Measure: Efficacy (diseappearance of lesions)
16 Unknown  The Effects of Potassium Citrate on Bone Metabolism
Conditions: Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal
Intervention: Drug: Potassium citrate
Outcome Measures: Bone turnover markers;   Bone Density by DEXA
17 Recruiting Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity
Condition: Dentin Sensitivity
Intervention: Device: Potassium oxalate
Outcome Measure: Dentin sensitivity
18 Recruiting Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
Conditions: Glomerulonephritis;   Proteinuria
Interventions: Drug: Shenyankangfu tablets;   Drug: Losartan Potassium 50mg;   Drug: Shenyankangfu tablets and Losartan Potassium 50mg;   Drug: Shenyankangfu tablets and Losartan Potassium 100mg;   Drug: Losartan Potassium 100mg
Outcome Measures: changes of 24 hours proteinuria after the treatment;   changes of serum creatinine after treatment;   changes of eGFR after the treatment;   changes of Traditional Chinese Medicine syndrome scores after the treatment
19 Recruiting Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment
Condition: Cough
Interventions: Drug: Syrup of oxomemazine, guaifenesin and Potassium iodate;   Drug: Syrup of guaifenesin
Outcome Measures: Reduction/improvement of cough symptoms;   Tolerance
20 Unknown  Relationship Between Potassium Level in Venous Blood Samples Drawn and Heel Sticks In Infants and Newborns
Condition: Healthy Infants
Intervention:
Outcome Measure: Potassium Measurements